A potential
non-surgical future
for basal cell carcinoma
Basal cell carcinoma (BCC) is the most common form of skin cancer in the US. It affects over 3 million people each year, and 50% of patients experience a recurrence within 3 years. By joining a clinical trial, you can help discover a non-surgical treatment for this dangerous cancer.
How it works
The path to participation is simple.
Complete The Survey
Answer eight easy questions, and we’ll let you know whether or not you or your loved one may be eligible to participate in the study.
Schedule An Appointment
If you or a loved one qualify, the next step is speaking with a coordinator. Find 30 minutes that work for you, and we’ll get you connected.
Speak To A Recruitment Coordinator
We are here to help. Our dedicated coordinators understand your situation and will listen, answer any questions, and address concerns.
Who can participate?
To join the VP-315 study, participants must meet the following qualifications.
- At least 45-75 years old
- Diagnosis or suspected diagnosis of basal cell carcinoma
- Willing to attend up to six (6) in-person study visits over a two-week period
Read more about our participation requirements to see if you or you loved one are a good fit for the VP-315 study.
What are symptoms of basal cell carcinoma?
Basal cell carcinoma is hard to diagnose. To know for certain, consult with a medical professional.
Non-healing skin lesion
Skin spot that may have started like a pimple
Pink or flesh-colored translucent bump with dilated blood vessels
Skin spot that bleeds or scabs easily
Clinical trials make
a real difference
When you participate in a clinical study, you provide valuable information that could eventually lead to new treatments, and—with the right breakthrough—new outcomes. Take our short eight question survey to see if you or your loved one are a good fit. There is no obligation.
Frequently Asked Questions
What are the symptoms of basal cell carcinoma?
Signs may include:
- Non-healing skin lesion
- Skin spot that may have started like a pimple, but is getting slowly larger and will not go away
- Pink or flesh-colored translucent bump with dilated blood vessels
- Skin spot that bleeds or scabs easily
- Enlarging, fragile spot on the skin
Who should apply?
Someone should consider applying if he or she meets the following three criteria:
- Diagnosed with basal cell carcinoma or has a suspected growth
- Willing to attend up to six (6) in-person study visits over a two-week period
- Between 45-75 years old
Why participate?
The information learned from the study may help find new treatment options in the future for people with basal cell carcinoma. If you qualify for the study, you will receive the investigational treatment VP-315, with an injection directly into the tumor to cause cell death, which may offer a non-surgical option for patients suffering from skin cancer.
Patients will also have all enrolled lesions removed at the end of the study at no cost.
What are the costs to participate?
There is no cost to participate. Qualified participants do not pay for the study medication, clinic visits, or study-related medical procedures and laboratory tests. Participants will be compensated for the clinic visits they complete.
Will there be compensation for participation?
Yes. Qualified patients may receive up to $2,500 for their attendance at all scheduled study visits.
If you have additional questions, contact us anytime at [email protected]
A Better Path Forward
Worried about basal cell carcinoma?
Many people worry when basal cell carcinoma impacts them or someone they love. Participating in the VP-315 study can give you or your loved one access to medical experts who understand your situation and can help answer your most pressing questions.